baber/WOPTO huggingface dataset:
Patent NZ-551846-A (NZ)
Title: The production of membrane electrode assemblies and stacks thereof
Inventor: HIGHGATE DONALD JAMES
IPC: H01M14/00
Filed: 2005-06-16
Abstract: Disclosed is a method for the production of a membrane electrode assembly (MEA), by assembling the components thereof, including a membrane, electrodes and a catalyst, which comprises depositing solid catalyst particles on the surface of a transfer medium; introducing a monomer mixture into the space between two such catalyst-coated transfer media; polymerising the mixture in situ, whereby the catalyst is pressed into the membrane material; and peeling away the transfer media. Also disclosed is a method for the production of a membrane electrode assembly (MEA), by assembling the components thereof, including a membrane, electrodes and a catalyst, which comprises depositing solid catalyst particles on the surface of an electrode material; treating the particles to render the catalyst active and permanently attached to the electrode material; introducing a monomer mixture into the space between two such catalyst-coated electrode materials; and polymerising the mixture in situ, whereby the catalyst is pressed into the membrane material.
Patent NZ-561877-A (NZ)
Title: Device for dosing and dry nebulization
Inventor: EISTETTER KLAUS
IPC: A61M11/06
Filed: 2006-04-07
Abstract: The use of a nebulizer for the dosing and dry nebulisation of nebulizable material 12 chosen from the group comprising anti- infective agents and immunomodulators, where the nebulizer comprises a nebulisation channel 3 with a first attachment piece 18 and a second attachment piece 6/7, a source of compressed carrier gas connected to the first attachment piece 18 via a valve 16 for the purpose of sending a carrier gas pressure pulse into the nebulisation channel 3, and a nebulizable material reservoir 10 placed between the first attachment piece 13 and second attachment piece and open only towards the nebulisation channel 3. The reservoir 10 is connected to the nebulisation channel 3 such that it is gas-tight with respect to the environment. When the valve 16 is closed gas flows back to the nebulisation channel 3 and reservoir 10 to compensate for the pressure change.
Patent NZ-567515-A (NZ)
Title: Odorant mixture for odorless gas fuel
Inventor: CHARLES PATRICK
IPC: C10L3/10
Filed: 2006-10-10
Abstract: Disclosed is a comprising: from 0.1 to 49.9 parts by weight of at least one alkyl sulphide (I) of formula: R'- S - R2 in which R1 and R2, which are identical or different, represent an alkyl radical comprising from 1 to 4 carbon atoms; or R1 and R2, taken with the sulphur atom to which they are attached, represent a saturated or unsaturated ring; from 50 to 99.8 parts by weight of at least two alkyl acrylates (II), the alkyl radicals of which is a from 1 to 12 carbon atoms; from 0.001 to 0.1 part by weight of at least one compound (III), wherein the compound (III) comprises a stable nitroxide radical of formula (IV): in which: R3 and R4, which are identical or different, each represent a tertiary or secondary hydrocarbon radical comprising from 2 to 30 carbon atoms or R3 and R11, taken with the nitrogen atom to which they are attached, represent a cyclic hydrocarbon radical comprising from 4 to 10 carbon atoms e.g. N-(tertbutyl)- N-(1-[ethoxy(ethyl)phosphino]propyl) nitroxide, N-(tert-buty1)-N-(1-diethylphosphono-2,2-dimethylpropyl) nitroxide and/or N-(tert-butyl)-N-(2-methy1-1- phenylpropyl) nitroxide. Also disclosed is a process for the odorization of an odourless gaseous fuel comprising the addition of an effective amount of the composition.
Patent NZ-578249-A (NZ)
Title: Breast pump with an elastic liner which adapts to teat physiology
Inventor: FARKA ELONA
IPC: A01J5/00
Filed: 2008-01-17
Abstract: 578249 A system (500) and a method of eliciting milk from mammals with teats; there are embodiments for dairy animals and for humans. A system (500) includes an elastic system (100) and a vacuum supply (200). A method may include a milk elicitation system (500) with an elastic system (100) and a vacuum supply (200). Through the application of vacuum, the elastic system (100) forms, differentiates, seals and adapts to the shape of a teat. The teat is covered from teat end up to the udder but the elastic system does not come into contact with the sphincter/lactiferous duct(s). The elastic system (100) interacts proportionately to different teat physiology and dynamically adjusts according to milk pressure changes, blood flow changes, and the effects of applied vacuum, throughout the milk elicitation process.
Patent NZ-578719-A (NZ)
Title: Storage zone and refrigeration zone separated by divider having fan(s) to direct air into refrigeration zone and outlets to storage zone
Inventor: GUYOMAR DON
IPC: A23B7/04
Filed: 2009-07-29
Abstract: An integrated airflow control facility for force cooling of produce in a cool room (10), including a dedicated storage zone (1) for storage of the produce and a dedicated refrigeration zone (2) separated by a physical divider (34) in which the divider includes one or more integral extraction fans (24) to extract air form the storage zone and direct said air through refrigeration coils (40/42) positioned in said the refrigeration zone for cooling thereof, in which the divider further includes one or more air outlets (44/46) to direct the cooled air exiting the refrigeration zone into the storage zone and in which the storage zone, refrigeration zone and the physical divider are integrated into a single airflow control facility.
Patent NZ-584888-A (NZ)
Title: Bone-strengthening food material
Inventor: SERIZAWA ATSUSHI
IPC: A61K38/02
Filed: 2008-10-28
Abstract: Provided is a milk protein fraction having the following characteristics (1) to (4); (1) the milk protein fraction is derived from milk, (2) the milk protein fraction comprises proteins having a molecular weight of 6000 to 150,000 daltons determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), (3) the milk protein fraction comprises 12 to 14 wt% of basic amino acids in the constituent amino acid composition, and has a basic amino acid/acidic amino acid ratio of 0.5 to 0.7, and (4) the milk protein fraction has a promoting effect on the calcification in an osteoblast.
Patent NZ-586175-A (NZ)
Title: An icpt system, components and design method
Inventor: MISHRIKI FADY
IPC: H01F38/14
Filed: 2010-06-15
Abstract: 586175 Disclosed is a power transmitter (1) for an inductively coupled power transfer system. The transmitter (1) includes a transmitting coil (2) having an associated metallic casing and a transmitter circuit for the transmitting coil (2). The transmitter circuit is designed for operation of the transmitting coil (2) taking into account the effect of the associated metallic casing. Also disclosed is a power receiver (4) for an inductively coupled power transfer system. The receiver (4) includes a receiving coil (3) having an associated metallic casing that partially encloses the receiving coil (3) and a receiving circuit for the receiving coil (3). The receiving circuit is designed for operation of the receiving coil (3) taking into account the effect of the associated metallic casing.
Patent NZ-586774-A (NZ)
Title: Treatment of produce using an atmosphere of a cyclopropene compound and ethylene
Inventor: REGIROLI GIOVANNI
IPC: A01N3/00
Filed: 2010-07-13
Abstract: A method of treating harvested produce is disclosed, which comprises the step of exposing said produce to an atmosphere containing (i) 100 ppb to 5,000 ppb by volume of one or more cyclopropene compound, and (ii) ethylene, wherein the ratio of ethylene concentration by volume to cyclopropene concentration by volume is from 0.1:1 to 8:1, wherein said exposing is conducted at temperature of -1.5 Deg. C to 25 Deg. C, and wherein said produce preferably comprises one or more fruit selected from the group consisting of pome fruits and tropical fruits.
Patent NZ-589534-A (NZ)
Title: Combination of aromatase inhibitors and progesterone antagonists in the treatment of breast cancer
Inventor: PODOLSKI JOSEPH S
IPC: A61P35/00
Filed: 2009-04-27
Abstract: Disclosed is a combination comprising a 21-substituted 19-norpregnadiene of formula (I) and an aromatase inhibitor. Specific examples of aromatase inhibitors are anastrozole, letrozole, exemestane and DL-aminoglutethimide. Specific examples of compound of formula (I) include: 21-propionyloxy-17[alpha]-acetoxy-11[beta]-(4N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, and 21-vinyl ether-17[alpha]-acetoxy-11[beta]-(4N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione The combination is useful for suppressing breast cancer tissue proliferation
Patent NZ-592274-A (NZ)
Title: Antibodies against interleukin-25
Inventor: MATTHEWS DAVID JOHN
IPC: A61P1/00
Filed: 2009-09-30
Abstract: The VH domain of an antibody that binds to interleukin-25 (IL-25) and comprises the amino acid sequence of SEQ ID NO: 1: EVQLVESGAEVKKPGASVKVSCKASGYSFXXYTMNWVRQAPGQRLEWXGLINPYNGGTSYNQNFKGRVTLTXDTSASTAYLELNSLRSEDTGVYYCAREXYDGYLYFAMDYWGQGTLVTVSS The VH domain can be used in conjunction with a VL domain to create an antibody. The antibody can be used for treating asthma, inflammatory bowel disease, ulcerative colitis or Crohn's disease.
Patent NZ-597314-A (NZ)
Title: Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections
Inventor: DEPLA ERIK
IPC: C07K16/10
Filed: 2010-06-07
Abstract: Disclosed is polypeptide that comprises or essentially consists of at least one amino acid sequence and/or one or more Nanobody®, where hereinafter a Nanobody® is defined as an amino acid sequence with the structure FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4 in which FR1 to FR4 refer to framework regions 1 to 4, respectively, and in which CDR1 to CDR3 refer to the complementarity regions 1 to 3, such that said one or more Nanobody ® is directed against and/or specifically binds protein F of hRSV, wherein the at least one amino acid sequence and/or one or more Nanobody® is chosen from the following:- a) Sequences such as DVQLLESGGGLVQPGGSLRLSCAASGGSLSNYVLGWFRQAPGKGREFVAAINWRDDITIG PPNVEGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCGAGTPLNPGAYIYDWSYDYWGQGT LVTVSS; b) amino acid sequences that have no more than 3 amino acid difference with one of sequences such as DVQLLESGGGLVQPGGSLRLSCAASGGSLSNYVLGWFRQAPGKGREFVAAINWRDDITIG PPNVEGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCGAGTPLNPGAYIYDWSYDYWGQGT LVTVSS, provided that: i) the amino acid sequence has a Aspartic acid (Asp, D) at position 1, where said position is determined according to Kabat numbering; and ii) the amino acid sequence binds protein F of hRSV with the same, about the same, or a higher affinity and/or the amino acid sequence has the same, about the same, or a higher potency compared to the amino acid sequence without the 3, 2 or 1 amino acid difference.
Patent NZ-598118-A (NZ)
Title: Safety line traveller
Inventor: JONES OWAIN
IPC: A62B35/04
Filed: 2010-09-01
Abstract: 598118 A traveller (1) for safety line for a fall arrest system having a slot (4) extending to the exterior of the traveller (1) and a safety line locating shuttle (15) provided on-board the traveller (1). The safety line locating shuttle (15) is movable relative to the slot (4) along a predetermined path in a direction across the slot (4). This aids in accurate positioning of the safety line with respect to the traveller (1). The shuttle (15) embraces and guides the safety line within the traveller (1).
Patent NZ-601307-A (NZ)
Title: Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
Inventor: RUF SVEN
IPC: A61K31/415
Filed: 2011-01-26
Abstract: The disclosure relates to relates to compounds of the formula I, wherein A, D, E, G, R10, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful for the treatment of diseases such as atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases, for example. The disclosure furthermore relates to processes for the preparation of the compounds of the formula I, their use and pharmaceutical compositions comprising them. Compounds of formula I include: (S)-3-{ [1-(2-Fluoro-phenyl)-5-((S)-2-hydroxy-2,3,3-trimethyl-butoxy)-1H-pyrazole-3-carbonyl]-amino} -3-o-tolyl-propionic acid, 3-{ [1-(2-Fluoro-phenyl)-5-hydroxy-1H-pyrazole-3-carbonyl]-amino} -3-(4-methanesulfonyl-phenyl)-propionic acid, 3-[(5-Hydroxy-1-phenyl-1H-pyrazole-3-carbonyl)-amino]-3-(4-methoxy-phenyl)propionic acid and (S)-3-{ [1-(2-Chloro-phenyl)-5-((S)-2-hydroxy-3,3-dimethyl-butoxy)-1H-pyrazole-3-carbonyl]-amino} -3-phenyl-propionic acid.
Patent NZ-607043-A (NZ)
Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
Inventor: BORODY THOMAS JULIUS
IPC: A61K35/742
Filed: 2011-08-04
Abstract: Disclosed is an oxygen-free or substantially oxygen-free delivery vehicle comprising: a faecal microbiota selected from a transplantable entire or substantially entire faecal microbiota; a transplantable treated or untreated faecal flora; a transplantable complete or partial faecal flora, a transplantable faecal flora substantially or completely purified of non-faecal floral faecal material, a transplantable entire or substantially entire cultured microbiota or a transplantable partially, substantially or completely isolated or purified faecal flora, made by a process comprising: (i) providing an entire or substantially entire faecal microbiota, a treated or untreated faecal flora sample, a complete or partial faecal flora sample, a faecal flora substantially or completely purified of non-faecal floral faecal material, an entire or substantially entire cultured microbiota, or a partially, substantially or completely isolated or purified faecal flora; and a delivery vehicle, and (ii) placing the entire or substantially entire faecal microbiota, the treated or untreated faecal flora sample, the complete or partial faecal flora sample, the faecal flora substantially or completely purified of non-faecal floral faecal material, the entire or substantially entire cultured microbiota, or the partially, substantially or completely isolated or purified faecal flora in the delivery vehicle, wherein a stabilising agent, trehalose, or a glycerol is added to, or mixed into, the entire or substantially entire faecal microbiota, the treated or untreated faecal flora sample, the complete or partial faecal flora sample, the faecal flora substantially or completely purified of non-faecal floral faecal material, the entire or substantially entire cultured microbiota, or the partially substantially or completely isolated or purified faecal flora; and (iii) creating or maintaining a substantially or completely oxygen-free environment in the delivery vehicle by using or adding an oxygen scavenging material or oxygen scavenging mechanism.
Patent NZ-613049-A (NZ)
Title: Safety line anchor
Inventor: BISSETT TIMOTHY
IPC: E04G21/32
Filed: 2012-01-25
Abstract: Disclosed is an anchor arrangement (10) for a safety line (7). The anchor arrangement (10) allows the safety line (7) to be secured in various orientations using an alignment collar (5) including an arcuate outer bearing surface articulating against an inclined bearing surface of a bracket (1). The anchor arrangement (10) is for use with the bracket (1) to secure a structure for mounting the safety line. The anchor arrangement comprises the alignment collar (5); a resilient biasing means (2) and a tension indicating means (3). The alignment collar (5) is arranged to sit in a seat provided on the bracket (1). The alignment collar (5) is capable of being seated in a plurality of different orientations with respect to the bracket (1). The resilient biasing means (2) acts between the bracket (1) and the tension indicating means (3).
Patent NZ-615270-A (NZ)
Title: Phosphoramidate derivatives of 5 - fluoro - 2 ‘ - deoxyuridine for use in the treatment of cancer
Inventor: MCGUIGAN CHRISTOPHER
IPC: C07H19/10
Filed: 2012-02-29
Abstract: Provided are phosphoramidate derivative compounds of 5-fluoro-2’-deoxyuridine, of general formula I, where the variables are as defined in the specification. Examples of the compounds include 5-Fluoro-2’-deoxyuridine-5’-O-[phenyl(benzoxy-L-alaninyl)] phosphate and 5-Fluoro-2’-deoxyuridine-5’-O-[phenyl(ethoxy-L-valinyl)] phosphate. The compounds are useful in the treatment of cancer.
Patent NZ-622728-A (NZ)
Title: Use of 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methylpropyl]amino-3,4-dihydro- 2h-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastases
Inventor: VACHER BERNARD
IPC: A61P35/04
Filed: 2012-09-12
Abstract: Provided is the use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine for treating cancer, and in particular preventing and/or treating cancer metastases.
Patent NZ-706637-A (NZ)
Title: Pr13.5 promoter for robust t-cell and antibody responses
Inventor: STEIGERWALD ROBIN
IPC: A61K39/285
Filed: 2013-10-28
Abstract: The invention encompasses recombinant poxviruses, preferably modified Vaccinia Ankara (MVA) viruses, comprising a Pr13.5 promoter operably linked to a nucleotide sequence encoding an antigen and uses thereof. The invention is drawn to compositions and methods for the induction of strong CD8 T cell and antibody responses to a specific antigen(s) by administering one or more immunizations of the recombinant MVA to a mammal, preferably a human.
Patent NZ-709157-A (NZ)
Title: Methods and comp0stions for treatment of demyelinating diseases
Inventor: BLITZER JEREMY
IPC: A61P35/00
Filed: 2014-01-08
Abstract: Disclosed herein are new oral pharmaceutical compositions of SAMDC inhibitors, polyamine analogs, and polyamine biosynthesis inhibitors, and their application for the treatment of conditions including demyelinating diseases, autoimmune disorders affecting the nervous system, and other neurodegenerative conditions. Specifically, the use of methylglyoxal bis(guanylhydrazone) (MGBG) in the manufacture of a medicament for the treatment of progressive multiple sclerosis is claimed. The medicament may be formulated for co-administration with fingolimod.
Patent NZ-714051-A (NZ)
Title: Packaging unit and method for packing products
Inventor: HOEKSTRA HENDRIK CHRISTIAAN ADOLF
IPC: B65D85/32
Filed: 2014-04-15
Abstract: The present invention relates to a packaging unit for products like eggs, and a method for packing products. Current packaging units have labels that limit recycling possibilities. The present invention has for its object to obviate, or at least reduce, the restriction for recycling possibilities on known packaging units with a paper label. The present packaging unit has a container made of moulded pulp with a bottom part for holding a product, and a label made of moulded pulp comprising an embossing with the label being attached to the container.
Patent NZ-717661-A (NZ)
Title: System and method for adjusting alignment of a panel
Inventor: ANGUS NOBLE
IPC: E06B3/62
Filed: 2016-03-03
Abstract: A flat panel (2) of a balustrade or partition may be aligned with its major face in a substantially vertical plane, even when the trough (4) is located with its base substantially not horizontal. In addition, the panel (2) may be held in the base of the trough (4) by the force of an adjustment part (16) on a first joint surface (12), thereby increasing stability of the panel (2). This is achieved by means of the first joint surface (34) being inclined obliquely to a substantially planar contact surface of a gripping part (12) for engaging with a face of the flat panel (2), such that a force being applied onto the first joint surface (34) results in the gripping part (12) gripping the panel (2) and urging the panel (2) toward the base of the trough (4). Furthermore, adjustment of the panel (2) may be made more simply than in prior art methods by means of the adjustment part (16) being more accessible to a user.
Patent NZ-718952-A (NZ)
Title: System and method for encryption key management, federation and distribution
Inventor: WHITE CHARLES
IPC: H04L9/08
Filed: 2014-10-03
Abstract: Systems and methods are described for orchestrating a security object, including, for example, defining and storing a plurality of policies in a database coupled to a policy engine and receiving, by the policy engine, the security object and at least one object attribute associated with the security object. In addition, the policy engine determines the acceptability of the security object based, at least in part, on the at least one object attribute and at least one of the plurality of policies corresponding to the at least one object attribute. The security object to at least one communication device associated with the policy engine is distributed when the security object is determined to be acceptable. The at least one communication device establishes communication based, at least in part, on the security object.
Patent NZ-737873-A (NZ)
Title: Seed treatment methods and compositions
Inventor: SMITH R STEWART
IPC: A01N63/02
Filed: 2012-09-10
Abstract: A method of enhancing plant growth, comprising treating a seed at least one month prior to planting with a flavonoid wherein, upon harvesting, the plant that grows from said seed exhibits at least one of increased plant yield measured in terms of bushels/acre, increased root number, increased root length, increased root mass, increased root volume and increased leaf area, as compared to a plant harvested from a control seed treated with the flavonoid just prior to or within a week or less of planting. The method further comprises treating plant seed with an agriculturally beneficial agent selected from the group consisting of phosphate solubilizing microorganisms, Rhizobium leguminosarum, Sinorhizobium, Sinorhizobium meliloti, metalaxyl, clothianidin, mefenoxam, fludioxonil, thiamethoxam, imidacloprid, chitin and chitosan.
Patent NZ-738968-A (NZ)
Title: Headgear with covered edge
Inventor: KOOIJ MICHIEL
IPC: A41D13/00
Filed: 2016-07-21
Abstract: A headgear assembly for a breathing mask, the headgear assembly comprising a strap of a first flexible material with a first elongate edge and a second elongate edge that together define a width of the strap, a first strip of second flexible material folded around and running along the first elongate edge, and a second strip of second flexible material folded around and running along the second elongate edge. The first strip of second flexible material and the second strip of second flexible material are an elastic material with a higher degree of elasticity than the first flexible material, wherein the first strip of second flexible material does not extend over the entire width of the strap, wherein the second strip of second flexible material does not extend over the entire width of the strap and is not connected to the first strip of second flexible material, and wherein the second strip of second flexible material has different material properties than the first strip of second flexible material. This configuration allows the user to select materials with different properties for each strip, for example different elastic properties.